Margaret McGowan

Margaret McGowan

Auto-generated profile, based on publicly available information

Margaret McGowan

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine Monash University Clayton Victoria Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2024 in Obesity Reviews
Verified
Journal Article
Closed access
MMMargaret McGowan
Margaret McGowan
RGRhonda Garad
Rhonda Garad
GWGirija Wadhwani
Girija Wadhwani
STSophia Torkel
Sophia Torkel
VRVibhuti Rao
Vibhuti Rao
SCStephanie Cowan
Stephanie Cowan

9 July 2025 in Obesity Reviews
Verified
Journal Article
Open access
EOElaine Osei-Safo
Elaine Osei-Safo
JMJennifer McIntosh
Jennifer McIntosh
SOShakira Onwuka
Shakira Onwuka
STSophia Torkel
Sophia Torkel
MMMargaret McGowan
Margaret McGowan
LMLisa Moran
Lisa Moran
Introduction: Cardiometabolic pregnancy complications increase future cardiometabolic disease risk. Accurate risk perception plays a central role in adopting risk‐reducing lifestyle and health‐related behaviors, such as healthy eating, physical activity, and weight management. This review aimed to explore high‐risk pregnant and postpartum women's perception of their risk of developing cardiometabolic pregnancy complications or future cardiometabolic disease.Methods: Systematic search identified quantitative and qualitative data exploring risk perception in women (pregnant/postpartum) at risk of or diagnosed with gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), intrauterine growth restriction (IUGR), and preterm birth (PTB). A convergent integrated mixed‐methods synthesis was undertaken, with findings interpreted using the health belief and capability, opportunity, and motivation for behavior change models.Results: Overall, 84 studies were included, with the majority in GDM (77.4%) and HDP (23.8%), with limited research in PTB (8.3%) and IUGR (6.0%). Women had low–moderate knowledge of pregnancy complications as risk factors for future cardiometabolic disease and low–moderate perceived susceptibility to potential pregnancy complications and future cardiometabolic disease. Self‐perceived barriers, facilitators, cues to action, self‐efficacy, and self‐optimism impacted engagement with lifestyle and screening measures. The highest risk perception for future type 2 diabetes or cardiovascular disease was among women who had previously experienced GDM or HDP, respectively.Conclusion: Designing interventions to optimize women's risk perception will support informed decision‐making and empower women to make lifestyle changes to reduce future cardiometabolic risk.

22 August 2025 in Human Reproduction Update
Verified
Journal Article
Open access
STSophia Torkel
Sophia Torkel
Evangeline MantziorisEvangeline Mantzioris
Evangeline Mantzioris
Anthony VillaniAnthony Villani
Anthony Villani
NKNicole Kellow
Nicole Kellow
DBDhruv Bhatnagar
Dhruv Bhatnagar
LMLisa Moran
Lisa Moran
BACKGROUND: The time before conception is an important opportunity to improve maternal lifestyle, and hence improve fertility and health. However, the components of effective preconception lifestyle interventions are unclear. OBJECTIVE AND RATIONALE: This review aimed to assess the association of intervention characteristics and behaviour change techniques with the effect of lifestyle interventions on fertility, obstetric, foetal, anthropometric, and metabolic outcomes in women planning a pregnancy. Understanding the optimal components of preconception lifestyle interventions is essential to improve success of future interventions. SEARCH METHODS: We searched Ovid MEDLINE, PsycINFO, Embase, Emcare, Scopus, Cochrane Central Register of Controlled Trials, and CINAHL (6 December 2024). We included randomized controlled trials on women planning a pregnancy which assessed the effect of lifestyle intervention compared to standard minimal care or no intervention on fertility, obstetric, foetal, anthropometric, and metabolic outcomes. We performed random-effects meta-analysis with subgroup analysis based on participant characteristics, intervention characteristics (using the Template for Intervention Description and Replication (TIDieR) framework), and behaviour change techniques (using the Behaviour Change Taxonomy v1). We assessed trustworthiness (using the Trustworthiness in Randomised Controlled Trials (TRACT) checklist), risk of bias (using the Cochrane Risk of Bias 2.0 tool), and certainty of the evidence (using the GRADE approach). OUTCOMES: Following eligibility screening and trustworthiness assessments, we included 24 studies (n = 7795 women), of which the majority were conducted in high-income countries (79%) and studied women with infertility (67%). Risk of bias was low for seven studies, some concerns for 15 studies and high for two studies. Overall, there was no difference in clinical pregnancy (odds ratio [95% CI]: 1.06 [0.84, 1.35], I2 = 24.22%) or live birth (odds ratio [95% CI]: 1.17 [0.82, 1.67], I2 = 48.73%) with lifestyle intervention. Odds of clinical pregnancy were higher for interventions delivered over ≥10 sessions (2.17 [1.21, 3.86] vs 0.88 [0.72, 1.07], P = 0.004 for subgroup differences) and with the behaviour change technique Adding objects to the environment (e.g. provision of intervention-compliant food and/or exercise equipment) (3.51 [1.70, 7.23] vs 0.90 [0.75, 1.08], P < 0.001 for subgroup differences). Lifestyle interventions reduced weight (mean difference [95% CI]: −3.87 kg [−5.76, −1.97], I2 = 95.03%) and fasting blood glucose (mean difference [95% CI]: −0.15 mM [−0.25, −0.04], I2 = 0%). Greater weight loss was observed for interventions with a weight loss aim (−4.19 kg [−6.30, −1.92] vs −0.81 kg [−1.48, −0.14], P = 0.003 for subgroup differences). Greater weight loss was observed for interventions delivered solely via face-to-face (−6.02 kg [−8.96, −3.07]) compared to those delivered via a combination of face-to-face and technology (−2.21 kg [−3.62, −0.81], P = 0.02 for subgroup differences). WIDER IMPLICATIONS: Effectiveness of preconception lifestyle interventions aiming to enhance fertility may be improved by a structured, intensive approach. Preconception lifestyle interventions reduce weight, particularly face-to-face interventions with a weight loss aim. However, these findings based on subgroup analyses should be interpreted with caution and warrant further investigation due to the exploratory nature of the analysis, limited number of studies included, and potential aggregation bias of study-level subgroup effects. Selection of intervention characteristics for future preconception lifestyle interventions should consider patient preferences and practical considerations. REGISTRATION: This review was prospectively registered in the Prospective Register of Systematic Reviews (PROSPERO) (CRD42022333066).

19 December 2024 in Midwifery
Verified
Journal Article
Closed access
SLSarah Lang
Sarah Lang
JMJennifer G. McIntosh
Jennifer G. McIntosh
JEJoanne Enticott
Joanne Enticott
RGRebecca Goldstein
Rebecca Goldstein
SBSusanne Baker
Susanne Baker
SLSiew Lim
Siew Lim

Verified
Book
Closed access
PDF file
CBCathleen M. Bauschatz
Cathleen M. Bauschatz
JBJules Brody
Jules Brody
TCTerence Cave
Terence Cave
PDPhilippe Desan
Philippe Desan
CDClaude-Gilbert Dubois
Claude-Gilbert Dubois
ATAndré Tournon
André Tournon

14 August 2026 in Experimental Physiology
Verified
Journal Article
Open access
PDF file
MMMargaret McGowan
Margaret McGowan
SCStephanie Cowan
Stephanie Cowan
CTChau Thien Tay
Chau Thien Tay
LMLisa J. Moran
Lisa J. Moran
ANAshley H. Ng
Ashley H. Ng
Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological, lifestyle and/or traditional medicines. The aim of this narrative review is to explore the pathophysiology, treatment recommendations and current evidence for lifestyle management for those with PMOS. Using the consolidated framework for implementation research (CFIR) and capability, opportunity, motivation and behaviour (COM‐B) frameworks, this review identifies barriers and facilitators to implement lifestyle recommendations for PMOS, followed by strategies to support improvement in lifestyle management. There is limited high‐quality evidence to support specific physical activity and dietary recommendations for those with PMOS. Underlying physiological mechanisms driving PMOS can impact energy expenditure, metabolism, appetite and satiety hormones, acting as barriers for weight and lifestyle‐management strategies. Qualitative research suggests that implementation of lifestyle‐management strategies from the PMOS guidelines has not been adopted. From a psychosocial perspective, those with PMOS often report that their health needs are not being met by health professionals. This might be related to a disproportionate focus on weight‐focused care, inadequate lifestyle‐management education for health professionals and inadequate support for people with PMOS to achieve lifestyle management. Working in partnership with those who have lived experience is crucial to translate the PMOS guidelines to improve health professional education, resources and adaption of lifestyle‐management programmes to meet the needs of those with PMOS better.